Bilaketaren emaitzak - Zhuo, Jianyong
- Erakusten 1 - 14 emaitzak -- 14
-
1
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases nork Yang, Xinyu, Lu, Di, Zhuo, Jianyong, Lin, Zuyuan, Yang, Modan, Xu, Xiao
Argitaratua 2020Text -
2
The ongoing trends of patient‐derived xenograft models in oncology nork Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao
Argitaratua 2020Text -
3
-
4
High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma nork Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen
Argitaratua 2019Text -
5
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 nork Ling, Sunbin, Xie, Haiyang, Yang, Fan, Shan, Qiaonan, Dai, Haojiang, Zhuo, Jianyong, Wei, Xuyong, Song, Penghong, Zhou, Lin, Xu, Xiao, Zheng, Shusen
Argitaratua 2017Text -
6
Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma nork Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao
Argitaratua 2020Text -
7
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts nork Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao
Argitaratua 2021Text -
8
CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma nork Zhuang, Runzhou, Lu, Di, Zhuo, Jianyong, Zhang, Xuanyu, Wang, Kun, Wei, Xuyong, Wei, Qiang, Wang, Wei, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen
Argitaratua 2017Text -
9
The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma nork Lu, Di, Yang, Fan, Zhuo, Jianyong, Yang, Modan, Lin, Zuyuan, Jin, Pingbo, Cai, Xuechun, Cen, Beini, Wang, Jianguo, Wei, Xuyong, Zheng, Shusen, Xu, Xiao
Argitaratua 2020Text -
10
A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study nork Shen, Xiaoyong, Yang, Fan, Yang, Pengfei, Yang, Modan, Xu, Lei, Zhuo, Jianyong, Wang, Jianguo, Lu, Di, Liu, Zhikun, Zheng, Shu-sen, Niu, Tianye, Xu, Xiao
Argitaratua 2020Text -
11
Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation nork Yang, Xinyu, Lu, Di, Wang, Rui, Lian, Zhengxing, Lin, Zuyuan, Zhuo, Jianyong, Chen, Hao, Yang, Modan, Tan, Winyen, Yang, Mengfan, Wei, Xuyong, Wei, Qiang, Zheng, Shusen, Xu, Xiao
Argitaratua 2021Text -
12
Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy nork Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao
Argitaratua 2021Text -
13
Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021) nork Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao
Argitaratua 2021Text -
14
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib nork Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao
Argitaratua 2021Text